Guardian Pharmacy (GRDN) news
Recent news
Guardian Pharmacy Services, Inc.: Truist Securities raises target price to $51 from $47
Truist Securities has raised its price target for Guardian Pharmacy Services, Inc. (NYSE: GRDN) to $51 from $47, reflecting a more optimistic outlook for the company’s financial performance and strategic direction. This adjustment aligns with the firm’s updated assumptions regarding revenue growth,…
AInvest Wire · Sep 21, 2026Guardian Pharmacy Services acquires assets of Tennessee-based Nautilus Pharmacy
AInvest Wire · Sep 1, 2026Guardian Pharmacy Services Inc outlook FY revenue USD 1,430-1,450 million
AInvest Wire · Aug 6, 2026Guardian Pharmacy Services Inc FY2026 rev view $1.41 bln - LSEG IBES data
Guardian Pharmacy Services Inc. (NYSE: GRDN) is projected to generate revenue of approximately $1.41 billion for fiscal year 2026, according to data from LSEG IBES. This figure aligns with the company’s updated revenue guidance of $1.40 billion to $1.42 billion, which accounts for the impact of…
AInvest Wire · Aug 6, 2026Guardian Pharmacy Services to buy Wellness Concepts
AInvest Wire · Jul 1, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.